2012
DOI: 10.1074/jbc.m112.360065
|View full text |Cite
|
Sign up to set email alerts
|

Increased Activation of Hereditary Pancreatitis-associated Human Cationic Trypsinogen Mutants in Presence of Chymotrypsin C

Abstract: Background: Hereditary pancreatitis is caused by mutations in human cationic trypsinogen. Chymotrypsin C (CTRC) is a proteolytic regulator of trypsinogen activation. Results: Clinically relevant trypsinogen mutations increase autoactivation in the presence of CTRC. Conclusion: Pathological trypsinogen activation in hereditary pancreatitis is dependent on CTRC. Significance: Therapeutic suppression of trypsinogen autoactivation is warranted in carriers of pancreatitis-causing mutations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
144
1

Year Published

2015
2015
2018
2018

Publication Types

Select...
4
3

Relationship

3
4

Authors

Journals

citations
Cited by 86 publications
(148 citation statements)
references
References 34 publications
3
144
1
Order By: Relevance
“…Mutations in the best characterized risk genes PRSS1 (cationic trypsinogen), SPINK1 (pancreatic secretory trypsin inhibitor), and CTRC (chymotrypsin C) stimulate activation of trypsinogen and result in elevated trypsin activity in the pancreas [4][5][6][7][8][9]. More recently, loss-of-function variants in the CPA1 gene encoding carboxypeptidase A1 were shown to increase risk for early onset CP [10].…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in the best characterized risk genes PRSS1 (cationic trypsinogen), SPINK1 (pancreatic secretory trypsin inhibitor), and CTRC (chymotrypsin C) stimulate activation of trypsinogen and result in elevated trypsin activity in the pancreas [4][5][6][7][8][9]. More recently, loss-of-function variants in the CPA1 gene encoding carboxypeptidase A1 were shown to increase risk for early onset CP [10].…”
Section: Introductionmentioning
confidence: 99%
“…Hereditary pancreatitis is an autosomal dominant disorder caused by mutations in PRSS1 that result in increased intra-pancreatic trypsinogen activation (8,9). The mutations alter cleavage of regulatory nick sites by chymotrypsin C (CTRC) 2 and trypsin that control trypsinogen degradation and autoactivation (10).…”
mentioning
confidence: 99%
“…CTRC-mediated degradation effectively curbs autoactivation of trypsinogen, resulting in diminished trypsin levels. Importantly, a single mutation of either Leu-81 or Arg-122 is enough to stabilize cationic trypsinogen and allow robust autoactivation even in the presence of CTRC (10).…”
mentioning
confidence: 99%
See 2 more Smart Citations